Mycotoxins - background

In the contemporary global food supply chain, mycotoxin management has transitioned from a baseline regulatory requirement to a critical determinant of brand integrity and consumer safety. As secondary metabolites produced by filamentous fungi, mycotoxins—such as Aflatoxins, Ochratoxin A, and Deoxynivalenol (DON)—pose chronic and acute health risks, including carcinogenicity and immunosuppression.

Within the European Union, the regulatory landscape is governed by Regulation (EU) 2023/915, which mandates strict maximum levels (MLs) for contaminants in foodstuffs. To navigate these complexities, a resilient safety program must integrate a multi-layered analytical suite that meets EFSA standards and supports GFSI certifications.

1. The Quantitative Benchmark: ELISA Screening

The Enzyme-Linked Immunosorbent Assay (ELISA) remains the primary high-throughput tool for the rapid quantification of mycotoxins. By utilizing competitive binding immunoassays, ELISA provides the sensitivity required for large-scale raw material monitoring and initial compliance screening.

• Application: Raw material intake, high-volume screening, and internal risk grading.
• Performance: High sensitivity for Aflatoxins and Ochratoxin A at the ppb (parts per billion) level.
• Key Advantage: Offers a cost-effective, rapid assessment of batch contamination before processing, allowing for immediate "go/no-go" decisions.

2. Definitive Identification: LC-MS/MS (The Gold Standard)

For regulatory enforcement, Liquid Chromatography with Tandem Mass Spectrometry (LC-MS/MS) is the ultimate analytical pillar. To achieve absolute accuracy in complex matrices, we utilize a sophisticated Isotope Dilution strategy.

• Reference Standards: We employ both Native Standards for calibration and 13C Stable Isotope-Labeled Internal Standards.
• The 13C Advantage: By spiking samples with 13C-labeled mycotoxins, we compensate for matrix effects and recovery losses during extraction. The labeled molecules behave identically to the native toxins but are easily distinguished by the mass spectrometer, providing a "gold standard" for precision.
• Technical Edge: Essential for detecting "masked" mycotoxins (e.g., DON-3-glucoside) which traditional tests may miss but which release free toxins during digestion.

3. Operational Agility: Lateral Flow Devices (LFD)

To maintain momentum in the production environment, Lateral Flow Devices provide rapid immunochromatographic diagnostics at the point of receipt.

• Application: Grain elevator testing, field-side screening, and real-time intake monitoring.
• Efficiency: Delivers quantitative or semi-quantitative results in <15 minutes with minimal sample preparation.

4. Advanced Clean-Up: Immunoaffinity Columns (IAC)

The complexity of food matrices (e.g., spices, coffee, cocoa) can interfere with detection. We utilize Immunoaffinity Columns for selective extraction and concentration of the target mycotoxin.

A Resilient Strategy for Chemical Safety

A defensible mycotoxin management program necessitates the strategic integration of LC-MS/MS precision and LFD speed. By harmonizing laboratory depth with operational screening, manufacturers can navigate the complexities of EU 2023/915 with absolute confidence.

This multi-layered approach ensures that the food supply chain is scientifically verified, protecting both the consumer and the manufacturer from the legal and reputational risks associated with chemical contaminants. As climate volatility increases the risk of fungal proliferation, we provide the technical expertise required to maintain a secure and transparent supply chain.